States' Generic Drugs Antitrust Case Headed Toward Trial

By Hailey Konnath · February 13, 2026, 10:42 PM EST

A Connecticut federal judge has mostly refused to side with pharmaceutical companies facing states' generic drug price-fixing litigation against them, ruling that there are genuine disputes of material fact as to...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Connecticut et al v. Sandoz, Inc. et al

Case Number

Court

Connecticut

Nature of Suit

Anti-Trust

Date Filed

June 10, 2020

Recent Articles By Hailey

February 13, 2026
RFK Jr. Taps Ex-Jones Day Atty For FDA Senior Counselor
February 11, 2026
AbbVie Sues Medicaid, HHS Over Botox Fair Price Controls
February 04, 2026
'Careless Or Disingenuous': Judge Rips CareFirst Rethink Bid
January 09, 2026
Mylan, Aurobindo Must Face Generic Drug Price-Fixing Claims
January 05, 2026
1st Circ. Upholds Block On Trump Admin NIH Funding Cuts
November 24, 2025
HHS Says It Plans To Resume Sharing Medicaid Info With ICE
November 05, 2025
5th Circ. Judge Says FCA Illegally Steps On Executive Power
October 31, 2025
Drugmakers Can't End States' Dermatology Price-Fixing Suits
October 31, 2025
Amgen Again Challenges Colo. Price Cap For Arthritis Drug
October 30, 2025
Philly Accuses PBMs Of Knowingly Enabling Opioid Crisis